Medtronic Loss Contingency Accrual remained flat by 0.0% to $200.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $200.00M to $200.00M. Over 4 years (FY 2021 to FY 2025), Loss Contingency Accrual shows relatively stable performance with a 0.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher legal or operational risk, while a decrease may indicate the resolution of past contingencies.
This represents the estimated liability for potential losses from legal proceedings, environmental claims, or other unce...
Standard accounting practice; peers report this based on their specific legal and environmental exposure profiles.
other_loss_contingency_accrual_at_carrying_value| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $400.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $300.00M | $200.00M | $200.00M | $300.00M | $200.00M | $200.00M | $400.00M | $200.00M | $200.00M | $200.00M |
| QoQ Change | — | -25.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -33.3% | +0.0% | +50.0% | -33.3% | +0.0% | +100.0% | -50.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -25.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -33.3% | -33.3% | +0.0% | -33.3% | +0.0% | +100.0% | -33.3% | +0.0% | +0.0% |